Investigators conducted a meta-analysis of 4 randomized controlled trials including a total of more than 1000 men with prostate cancer.

High symptom scores for tiredness, poor well-being, pain, and drowsiness may prompt AYA patients with cancer to seek medical assistance in dying.

Investigators conducted a population-based study to characterize treatment rates, trends, and factors associated with the treatment of mNSCLC in elderly patients.

Investigators conducted a retrospective analysis at 19 trial sites where patients received at least one dose of the KEYNOTE-522 regimen for triple-negative breast cancer.

Researchers developed a model to predict risk of TIPN in patients with early-stage cancer treated with a taxane regimen.

Researchers evaluated patient goals for breast reconstruction after mastectomy, including reconstructive technique, timing, and mastectomy indication.

MRD testing showed weak trial-level correlation with progression-free survival in BTK inhibitor and venetoclax-based CLL studies.

In this study, researchers investigated the potential impacts of “shared decision-making” replacing universal HBV birth-dose vaccination on neonatal and later chronic HBV infections.

The Turkish version of the RCAC Scale demonstrated cultural relevance, validity, and reliability in assessing fertility concerns of women with cancer in this population.

Survey study compared facilitators and barriers to lymphoma clinical trial participation for non-Hispanic White, Hispanic, and African American and male and female patients.

Investigators constructed weighted methylation risk scores to pinpoint specific risk factors associated with early-onset CRC versus late-onset CRC.

Off-label dasatinib induced symptomatic and partial hematologic response, enabling successful curative-intent transplantation in an aggressive SM subtype.